Skip to main content
. 2022 Apr 4;19:50–74. doi: 10.1016/j.bioactmat.2022.03.039

Table 3.

Therapeutic applications of stem cell spheroids for tissue repair and regeneration.

Tissue Stem cell Formation method Spheroid size Seeding density In vivo model (Functional evaluation) Paracrine factors Ref.
Bone hADSC Microfibers, centrifugation 1.2 mm2 2 × 104 cells/100 μL Calvarial bone defect (Bone regeneration: 42.48 ± 10.84%) VEGF [169]
hADSC Nanofibers, centrifugation 0.425 mm2 4 × 104 cells Calvarial bone defect(Bone regeneration: 59.97 ± 18.33%) Non-analysis [168]
BMSC Ultra-Low Attachment plates 530 μm 1 × 104 cells Calvarial bone defect(Bone regeneration: 77.1 ± 4.1%) Non-analysis [170]
BMSC Nonadherent microwell plates 300 μm 1 × 104 cells Segmental bone defect(Bone volume: 58 mm3) VEGF [171]
Cartilage ADMSC Non-fouling scaffold 80–110 μm 5 × 107 cells/mL Articular cartilage defect(Collagen type II: 92%GAG: 89%) Non-analysis [175]
hADSC Porous scaffold 100–200 μm 5 × 107 cells/mL Articular cartilage defect(Collagen type II: 83%GAGs: 82%) TGF-β1 [176]
MSC Ultra-Low Attachment plates 291.3 μm 1 × 104 cells/well Osteochondraldefect(Cartilage tissue regeneration: 74.0 ± 5.9%) Non-analysis [178]
ASC Porous scaffold 80–110 μm 5 × 107 cells/mL Osteochondraldefect(Collagen type II: 81%,GAGs: 91%) [177]
ADSC Membrane ∼90 μm 8 × 104 cells/well Articular cartilage defect(High GAG expression) SDF-1 [179]
Nerve hGMSC Ultra-Low Attachment plates ∼500 μm 4 × 104 cells/well Facial nerve(High β-tubulin IIIand S-100 β expression) Non-analysis [188]
ADMSC Sulfonated chitosan well plate 2.8 × 104 cells/cm2 Nerve conduits(90% differentiation into immature Schwann cells; great peak amplitude and nerve conduction velocity) HGF, NGF, BDNF, GDNF, and SDF-1 [117]
Blood vessel hAMSC Porous hydrogel 200–300 μm 5 × 106 cells/mL Ischemic limb(Promoted angiogenesis, healthy myofiber, and regeneration of myofiber) VEGF and IGF-1 [192]
hAMSC Porous scaffold 220 μm 5 × 107 cells/mL Subcutaneous vascular ingrowth, and adipose tissue regeneration VEGF and FGF-2 [190]
Tooth hDPSC Agarose microwell ∼300 μm 2.6 × 105 cells/190 μL Regenerated and vascularized dental pulp-like tissue Non-analysis [194]
hDPSC Ultra-Low Attachment plates ∼60 μm 3.3 × 105 cells in 3 mL of pellet Regenerative dentin and neurovascular-like structures that mimicked the native teeth VEGF and TGF-β [195]
Skin hADSC Hanging drop 200–300 μm 8000−10000 cells/25 μL Skin wounds(Wound regeneration: 100%epithelium thickness: 150 μmcollagen density: 40%CD31 expression: 35%) IL-10 and TGF-β1 [200]
hADSC Ultra-Low Attachment plates 1.2–1.5 mm 7.5 × 104 cells/cm2 Skin wounds(Rapid wound closure andhigher histological score) VEGF, FGF, and HGF [199]
Human placenta-derived MSCs Hanging drop 100 μm 5000 cells/droplet Skin wound(Fast wound reepithelization and closure,enhanced microvessel density, andhigher expression of paracrine factors) VEGFa, SDF-1, and Ang1 [197]
Heart hBMSC Hanging drop 260 μm 3 × 105 cells Myocardial infarction(Enhanced vascularization, enhanced Cx43 expression, and improved cardiac function VEGF, FGF, and HGF [250]
Human cardiac stem cell Ultra-Low Attachment plates 95 μm 5 × 105 Myocardial infarction(Enhanced neovascularization, decreased fibrotic area, increased left ventricle thickness, and improved cardiac function) FGF1, FGF2, FGF4, FGF5, FGF7, FGF16, IGF1, NGFβ, NRG4, ZEP91, ANGPT4, EFNA1, EFNA5, EFNB3, PDGFC, VEGFC, GH1, IFNA1, and IFNE1 [112]
Human cardiac stem cell 6-well tissue culture plates coated with poly-2-hydroxyethyl methacrylate 75 μm 1052 cells Myocardial infarction(Improved cardiac function and decreased fibrotic area) SDF-1α and MCP-1 [201]
Kidney hMSC Ultra-Low Attachment plates 241 μm 1500 cells Hypertensive kidney disease(Reduced proteinuria, improved glomerular permselective function) VEGFA, HGF, IGF, and SDF-1 [204]
hADMSC Hanging drop 200 μm 25,000 cells Ischemic kidney(Decreased creatinine and BUN levels, reduced tissue apoptosis and damage, and enhanced vascularization) VEGF, EGF, IGF, bFGF, HGF, and TSG-6 [113]
Liver hADMSC Hanging drop 500 μm 1 × 106 cells Hepatic fibrosis(Reduced hepatic fibrosis, decreased collagen I and collagen III expression, and improved liver function IGF-1, HGF, and IL-6 [114]
Human teeth-derived Stem cells Ultra-Low Attachment plates 1 × 105 cells Hepatic fibrosis(Reduced hepatic fibrosis and reduced bleeding) TGF-β1 [206]
human umbilical cord-derived -MSC Rocker system 111 μm 1 × 106 cells Acute liver failure(Activated liver regeneration, reduced necrosis, and improved regeneration of hepatocytes IFN-γ, IL-6, and TNF-α [251]
Lung hADMSC PDMS-based microwell 150 μm 1 × 105 cells Emphysema(Recovered alveolar damage and enhanced growth factor production) FGF-2, VEGF, and HGF [115]